[Federal Register Volume 65, Number 223 (Friday, November 17, 2000)]
[Notices]
[Pages 69574-69575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-29440]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA # 201F]


Controlled Substances: 2000 Aggregate Production Quota

AGENCY: Drug Enforcement Administration (DEA), Department of Justice.

ACTION: Notice of the revised 2000 aggregate production quota for 
marihuana.

-----------------------------------------------------------------------

SUMMARY: This notice establishes a revised 2000 aggregate production 
quota for marihuana, a Schedule I controlled substance in the 
Controlled Substances Act (CSA).

EFFECTIVE DATE: November 17, 2000.

FOR FURTHER INFORMATION CONTACT: Frank L. Sapienza, Chief, Drug & 
Chemical Evaluation Section, Drug Enforcement Administration, 
Washington, DC 20537, Telephone: (202) 307-7183.

SUPPLEMENTARY INFORMATION: Section 306 of the CSA (21 U.S.C. 826) 
requires that the Attorney General establish aggregate production 
quotas for each basic class of controlled substance listed in Schedules 
I and II. This responsibility has been delegated to the Administrator 
of the DEA by Section 0.100 of Title 28 of the Code of Federal 
Regulations. The Administrator, in turn, has redelegated this function 
to the Deputy Administrator, pursuant to Section 0.104 of Title 28 of 
the Code of Federal Regulations.
    On September 18, 2000, notice of a proposed revision to the 2000 
aggregate production quota for marihuana was published in the Federal 
Register (65 FR 56328). All interested persons were invited to comment 
on or object to this proposed aggregate production quota on or before 
October 3, 2000.
    The DEA did not receive any comments on the proposed revision. As 
such, the DEA has determined that the proposed 2000 aggregate 
production quota for marihuana is sufficient for the estimated 
scientific, research and development requirements.
    Therefore, under the authority vested in the Attorney General by 
Section 306 of the CSA of 1970 (21 U.S.C. 826), delegated to the 
Administrator of the DEA by Section 0.100 of Title 28 of the Code of 
Federal Regulations, and redelegated to the Deputy Administrator 
pursuant to Section 0.104 of Title 28 of the Code of Federal 
Regulations, the Deputy Administrator hereby orders the following 
revision to the 2000 aggregate production quota for the listed 
controlled substance, expressed in grams of manicured material (i.e. 
leaves, flowering tops, and seeds):

------------------------------------------------------------------------
                                                           Established
                                                           revised 2000
                       Basic class                          aggregate
                                                            production
                                                              quota
------------------------------------------------------------------------
Marihuana..............................................         350,000
------------------------------------------------------------------------

    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866. This action has been analyzed in accordance with 
the principles and criteria contained in Executive Order 13132, and it 
has been determined that this matter does not have sufficient 
federalism implications to warrant the preparation of a Federalism 
Assessment.
    The Deputy Administrator hereby certifies that this action will 
have no significant impact upon small entities whose interests must be 
considered under the Regulatory Flexibility Act, 5 U.S.C. 601 et seq. 
The establishment of aggregate production quotas for Schedules I and II 
controlled substances is mandated by law and by international treaty 
obligations. The quotas are necessary to provide for the estimated 
medical, scientific, research and industrial needs of the United 
States, for export requirements and the establishment and maintenance 
of reserve stocks. While aggregate production quotas are of primary

[[Page 69575]]

importance to large manufacturers, their impact upon small entities is 
neither negative nor beneficial. Furthermore, this action involves only 
one basic class of controlled substances. Accordingly, the Deputy 
Administrator has determined that this action does not require a 
regulatory flexibility analysis.

    Dated: November 7, 2000.
Julio F. Mercado,
Deputy Administrator.
[FR Doc. 00-29440 Filed 11-16-00; 8:45 am]
BILLING CODE 4410-09-M